Obatala Sciences, Inc. — Form D/A
Obatala Sciences, Inc. of NEW ORLEANS, LA, a company, filed a Form D amendment with the SEC on 2021-01-15. The offering totals $1.5M, of which $535K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-15
- Form: D/A
- Accession: 0001828551-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $535K
- Remaining: $965K
- Minimum investment: $10K
- Investors: 10
- Date of first sale: 2020-09-30
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-378042
Issuer
- Name: Obatala Sciences, Inc.
- CIK: 0001828551
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2000 LAKESHORE DRIVE, #4020, NEW ORLEANS, LA, 70148
- Phone: 504-300-0266
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Trivia Frazier | Director | New Orleans, LA |
| Jeffrey Gimble | Director | New Orleans, LA |
| Xiying Wu Gimble | Director | New Orleans, LA |
| Trivia Frazier | Executive Officer | New Orleans, LA |
| Jeffrey Gimble | Executive Officer | New Orleans, LA |
| Xiying Wu Gimble | Executive Officer | New Orleans, LA |
Other filings by this issuer (1)
More